Call Options

20 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$206.39 - $268.73 $2.44 Million - $3.17 Million
11,800 New
11,800 $2.44 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $1.33 Million - $1.93 Million
8,100 New
8,100 $1.91 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $275,565 - $315,375
-1,500 Reduced 62.5%
900 $189,000
Q1 2023

May 12, 2023

BUY
$191.89 - $259.92 $211,078 - $285,912
1,100 Added 84.62%
2,400 $484,000
Q4 2022

Feb 10, 2023

SELL
$197.11 - $250.07 $532,197 - $675,189
-2,700 Reduced 67.5%
1,300 $283,000
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $364,880 - $501,080
2,000 Added 100.0%
4,000 $787,000
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $367,434 - $544,320
1,800 Added 900.0%
2,000 $428,000
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $9.25 Million - $13.1 Million
-36,200 Reduced 99.45%
200 $57,000
Q3 2021

Nov 12, 2021

SELL
$372.64 - $458.3 $1.75 Million - $2.15 Million
-4,700 Reduced 11.44%
36,400 $15 Million
Q2 2021

Aug 13, 2021

SELL
$294.17 - $371.65 $1.71 Million - $2.16 Million
-5,800 Reduced 12.37%
41,100 $15.2 Million
Q1 2021

May 14, 2021

BUY
$249.67 - $299.48 $8.41 Million - $10.1 Million
33,700 Added 255.3%
46,900 $13.6 Million
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $9.75 Million - $11.1 Million
-43,900 Reduced 76.88%
13,200 $3.3 Million
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $2.58 Million - $3.33 Million
14,700 Added 34.67%
57,100 $12.9 Million
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $4.91 Million - $7.84 Million
41,300 Added 3754.55%
42,400 $7.39 Million
Q1 2020

May 14, 2020

BUY
$98.9 - $178.34 $39,560 - $71,336
400 Added 57.14%
1,100 $139,000
Q3 2019

Nov 08, 2019

SELL
$125.07 - $143.67 $225,126 - $258,605
-1,800 Reduced 72.0%
700 $93,000
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $296,160 - $356,520
2,400 Added 2400.0%
2,500 $355,000
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $2.3 Million - $3.21 Million
-21,900 Reduced 99.55%
100 $15,000
Q4 2018

Feb 13, 2019

SELL
$105.09 - $137.23 $4.56 Million - $5.96 Million
-43,400 Reduced 66.36%
22,000 $2.49 Million
Q3 2018

Nov 13, 2018

BUY
$112.11 - $134.54 $7.33 Million - $8.8 Million
65,400 New
65,400 $8.8 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.